Question 1

What do medical sources say about Ciprofloxacin (Cipro) during pregnancy?

Accepted Answer

1st Trimester: The NHS says ciprofloxacin is not usually used during pregnancy because other antibiotics are recommended, but a doctor may recommend it if those options are unsuitable or have not worked. Human results for miscarriage differ: a Danish cohort found no association, while a Quebec study and a later Norwegian study reported higher rates; the Norwegian study's bias analysis suggested infections may explain some of the link. A Danish cohort and a 2025 UTI study found no increase in first-trimester major malformations, although the newer study grouped ciprofloxacin with other fluoroquinolones. The FDA label's boxed warning says: “Fluoroquinolones, including CIPRO, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together,” including tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects; it says to “Discontinue CIPRO immediately and avoid the use of fluoroquinolones, including CIPRO, in patients who experience any of these serious adverse reactions” and to “Avoid CIPRO in patients with known history of myasthenia gravis.” Ask your provider about your situation. 2nd Trimester: The NHS says ciprofloxacin is not usually used during pregnancy because other antibiotics are recommended, but a doctor may recommend it if those options are unsuitable or have not worked. A controlled study of 200 fluoroquinolone-exposed pregnancies, including 105 ciprofloxacin exposures, found no group difference in prematurity or birth weight; the FDA label says the small studies cannot support definitive conclusions and most exposure was short term in early pregnancy. The FDA label's boxed warning says: “Fluoroquinolones, including CIPRO, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together,” including tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects; it says to “Discontinue CIPRO immediately and avoid the use of fluoroquinolones, including CIPRO, in patients who experience any of these serious adverse reactions” and to “Avoid CIPRO in patients with known history of myasthenia gravis.” Ask your provider about your situation. 3rd Trimester: The NHS says ciprofloxacin is not usually used during pregnancy because other antibiotics are recommended, but a doctor may recommend it if those options are unsuitable or have not worked. In a biomonitoring cohort of 2,475 pregnancies, third-trimester urinary ciprofloxacin concentrations were associated with hyperactivity and attention problems at age four; exposure was measured in urine, not confirmed prescriptions. A 2026 biomonitoring paper also linked first-trimester urinary ciprofloxacin with later ADHD symptom trajectories, but possible overlap with the earlier cohort is unresolved. The FDA label's boxed warning says: “Fluoroquinolones, including CIPRO, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together,” including tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects; it says to “Discontinue CIPRO immediately and avoid the use of fluoroquinolones, including CIPRO, in patients who experience any of these serious adverse reactions” and to “Avoid CIPRO in patients with known history of myasthenia gravis.” Ask your provider about your situation.

Question 2

What do medical sources say about Ciprofloxacin (Cipro) while breastfeeding?

Accepted Answer

LactMed says milk amounts are low and ciprofloxacin is acceptable while nursing with infant monitoring; it suggests avoiding breastfeeding for three to four hours after a dose, while noting that infant outcome evidence is limited. The FDA label says breastfeeding is not recommended during treatment and for two days after the last dose for most indications, or that milk be pumped and discarded; the NHS says it is not usually used but a doctor may recommend it if benefits outweigh risks. The FDA label's boxed warning says: “Fluoroquinolones, including CIPRO, have been associated with disabling and potentially irreversible serious adverse reactions that have occurred together,” including tendinitis and tendon rupture, peripheral neuropathy, and central nervous system effects; it says to “Discontinue CIPRO immediately and avoid the use of fluoroquinolones, including CIPRO, in patients who experience any of these serious adverse reactions” and to “Avoid CIPRO in patients with known history of myasthenia gravis.” Ask your provider about your situation.

Question 3

Where do sources disagree on Ciprofloxacin (Cipro) in pregnancy or breastfeeding?

Accepted Answer

Does ciprofloxacin use in early pregnancy increase miscarriage risk? Muanda et al. (2017) reported higher odds for ciprofloxacin exposure, and Boissiere-O'Neill et al. (2026 issue) reported a higher hazard; both studies were observational. Noergaard et al. (2022) found no association in a Danish cohort, and Loebstein et al. (1998) found no difference in spontaneous abortions in a small mixed-fluoroquinolone controlled study. MotherToBaby also describes over 2,000 first-trimester exposures without an increased chance, alongside the positive association reports. The studies use different populations and designs. Prescription records cannot confirm that a person took the medicine, and infections or infection severity can be related both to treatment and pregnancy outcomes; the newer Norwegian study's bias analysis found that underlying infections may account for some associations. The findings conflict, and the observational studies do not establish that ciprofloxacin caused miscarriage. The positive associations remain relevant, but the Danish cohort and controlled study did not find an association.

Ciprofloxacin

Ciprofloxacin — Breastfeeding

What the research shows

What's in it / what was tested

Sources disagree

Options sources describe

Beyond pregnancy

All sources